| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
889 |
823 |
$472K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
164 |
147 |
$43K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
117 |
111 |
$32K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,647 |
1,452 |
$8K |
| 80053 |
Comprehensive metabolic panel |
1,249 |
1,101 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
622 |
603 |
$6K |
| 87631 |
|
37 |
37 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
2,552 |
2,115 |
$2K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
12 |
12 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
278 |
275 |
$777.63 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
158 |
152 |
$450.81 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
153 |
141 |
$443.47 |
| 82607 |
|
188 |
179 |
$383.89 |
| 81015 |
|
263 |
232 |
$338.83 |
| 80061 |
Lipid panel |
201 |
198 |
$300.46 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$286.19 |
| 81001 |
|
204 |
184 |
$79.58 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
13 |
12 |
$54.73 |
| 84439 |
|
13 |
12 |
$19.56 |
| K1034 |
Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count |
48 |
12 |
$0.00 |